Trial
NCT01351675
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Phase IIITERMINATEDSAFETYConfidence: HIGH
Sponsor
Biogen
Collaborators
—
Condition
Renal Insufficiency, Chronic
Intervention
Placebo
Why stopped
IDMC recommendation for safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-29